Back to User profile » Mr Tae Won Kwak
Papers published by Mr Tae Won Kwak:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
![](cr_data/cache/submission_images/s141000/141920/18_oct_2017_141920_fig4_200_200_90.jpg)
Kwak TW, Lee HL, Song YH, Kim C, Kim JS, Seo SJ, Jeong YI, Kang DH
International Journal of Nanomedicine 2017, 12:7669-7680
Published Date: 17 October 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
Kwak TW, Park SB, Kim HJ, Jeong YI, Kang DH
OncoTargets and Therapy 2017, 10:137-144
Published Date: 22 December 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anticancer activity of streptochlorin, a novel antineoplastic agent, in cholangiocarcinoma
![](cr_data/cache/submission_images/s80000/80205/06_feb_2015_figure_3_200_200_90.jpg)
Kwak TW, Shin HJ, Jeong YI, Han ME, Oh SO, Kim HJ, Kim DH, Kang DH
Drug Design, Development and Therapy 2015, 9:2201-2214
Published Date: 16 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Defensive mechanism in cholangiocarcinoma cells against oxidative stress induced by chlorin e6-based photodynamic therapy
Lee HM, Chung CW, Kim CH, Kim DH, Kwak TW, Jeong YI, Kang DH
Drug Design, Development and Therapy 2014, 8:1451-1462
Published Date: 18 September 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
Kim DH, Jeong YI, Chung CW, Kim CH, Kwak TW, Lee HM, Kang DH
International Journal of Nanomedicine 2013, 8:1697-1711
Published Date: 30 April 2013